19 citations
,
March 1994 in “Fertility and sterility”
This study found that treatment with a GnRH agonist and estrogen and progestin replacement significantly improved hirsutism scores and hair growth rates in women with polycystic ovarian disease.
18 citations
,
August 2012 in “Journal of The American Academy of Dermatology”
This report describes a case where a sex reassignment patient on estrogentherapy experienced complete hair regrowth on a previously fully alopecic scalp.
7 citations
,
September 2023 in “Cancer Treatment Reviews”
This review highlights the possible impact of side effects from endocrine therapy on quality of life, emphasizing that these can lead to poor adherence and early treatment discontinuation in patients with hormone receptor positive early breast cancer, potentially worsening survival outcomes.
1 citations
,
July 2024 in “Journal of Plastic Reconstructive & Aesthetic Surgery”
In this study, older age was found to predict lateral hairline recession in TGNB AMAB individuals, while each year of feminizing hormone therapy in patients over 30 also predicted a decrease in lateral forehead length by 0.07 cm.
The post discusses a user's successful hair regrowth using finasteride, dutasteride, topical minoxidil, and estrogen over nine months. The user, who is male-to-female (mtf), reports significant regrowth and no side effects beyond typical hormone replacement therapy effects.
The conversation is about managing hair loss while on hormone replacement therapy (HRT) with estrogen and spironolactone. The user considers adding finasteride but decides to wait and see the effects of the current treatment.
A user started balding at 17 and began hormone therapy with cyproterone and estrogel, along with minoxidil, which helped regrow hair at the front but not the back. Another user shared their experience of limited regrowth with dutasteride and minoxidil, noting that longer periods of hair loss make recovery more difficult.
Taking finasteride or dutasteride with testosterone replacement therapy (TRT) can increase testosterone levels by blocking its conversion to DHT, potentially raising estrogen levels. Users suggest monitoring for high estrogen symptoms and possibly using an aromatase inhibitor like anastrozole if needed.
The user experienced significant hair regrowth and fullness after starting hormone replacement therapy (HRT) with sublingual estrogen and spironolactone, in addition to using a topical solution of minoxidil, finasteride, ketoconazole, and biotin. They noted initial shedding phases but emphasized that shedding is a sign of future growth.
a synthetic estrogen used topically as an anti-androgen
Alfatradiol: What does a form of estrogen have to do with hair loss in men?Alfatradiol (17α-estradiol) is a prescription topical hormone, licensed for androgenetic alopecia in Germany but not FDA-approved. The controlled trial evidence is in women, where it produced stabilisation rather than regrowth and was outperformed by minoxidil; no comparable placebo-controlled trial in men appears to have been published.